The global Balloon Angioplasty Market accrued earnings worth approximately 3.22 (USD Billion) in 2021 and is predicted to gain revenue of about 3.98 (USD Billion) by 2028, is set to record a CAGR of nearly 4.4% over the period from 2022 to 2028.
The global Balloon Angioplasty Market accrued earnings worth approximately 3.22 (USD Billion) in 2021 and is predicted to gain revenue of about 3.98 (USD Billion) by 2028, is set to record a CAGR of nearly 4.4% over the period from 2022 to 2028. The study provides an assessment and analysis of the Balloon Angioplasty Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).
Balloon angioplasty is a specially devised catheter with tiny balloons in a carefully guided artery to the blockage. It is then inflated for widening the opening of the artery and then increases the flow of blood to the heart. Afterward, the stent is placed in the artery at the time of this procedure for keeping the artery open. Then the balloon is shrunk and then removed from the artery. Precisely, balloon angioplasty is a kind of minimally invasive cardiac catheterization method that is utilized for opening narrow or blocked arteries.
The surge in minimally invasive surgeries and technological breakthroughs has steered demand for balloon angioplasty surgical procedures in recent years, thereby driving market trends. Moreover, an increase in cases of cardiac disorders will prop up the expansion of the balloon angioplasty market in years to come. Nevertheless, balloon angioplasty is restricted due to unpredictable procedural consequences owing to vessel recoil & dissection as well as high restenosis rate, thereby restricting the expansion of the balloon angioplasty industry. However, the launching of drug-eluting stents providing anti-proliferative agents has remarkably reduced the restenosis rate, thereby offsetting the impact of hindrances on market growth.
Furthermore, breakthroughs in intracoronary imaging techniques and adjunct pharmacotherapies will create new growth avenues for the balloon angioplasty industry in the ensuing years.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
North America To Make Notable Contributions Towards Regional Market Size By 2022-2028
The growth of the balloon angioplasty market in North America in forecasting years can be credited to the presence of giant players in the region. In addition to this, changing life patterns and an increase in the number of obese individuals prone to heart disorders due to unhealthy diet intake in countries such as the U.S. will prop up the expansion of the balloon angioplasty industry.
Key players profiled in the study and influencing the growth of the market are BIOTRONIK, Medtronic plc., Boston Scientific Corporation, Becton, Dickinson and Company, Cook Group Incorporated, Terumo Corporation, and Cardinal Health, Inc.